Back to News
Market Impact: 0.05
Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term
Source: zacks.com
Analyst Insights
Zacks promoted its Premium research service and Style Scores tool as a resource for value, growth, and momentum investors. The article contains no company-specific financial results, market data, or actionable investment development.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
More News
- Meta's standoff with Amazon over Muse could be a sign of things to come
- Meta is having a ChatGPT moment with Muse. What is it and what makes it so special
- A rare Microsoft bear warms up to the stock. Here's what changed their mind
- IT services stock is up 89%+ since July - our AI models picked it first
- Tesla Roadster reveal is creating a unique options opportunity, says Mike Khouw
- AI Agents Fuel a New Cybersecurity Boom
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Can ChatGPT or Claude Replace a Research Platform?
- How the 2026 Milan-Cortina Winter Olympics Will Reshape Company Revenues and Stock Performance